The adjunctive use of a centralised database in the monitoring of clozapine-related neutropenia.
To assess the effectiveness of centralised routine monitoring of blood counts in subjects receiving clozapine. A cohort study based on a prospective drug exposure database. Patients with schizophrenia in 38 specialised centres across Australia. The time from detection of neutropenia to the interruption of therapy, the time to recovery of the absolute neutrophil count, the eventual outcome of subjects developing neutropenia. A total of 1500 subjects were registered on the database. Seven subjects developed severe neutropenia (a neutrophil count < 1.5 x 10(9)/L) whilst on therapy. Mean time to cessation of therapy was 1.6 days (range < 1-6 days). Neutrophil counts recovered to normal levels in all subjects after 6.4 days (range < 1-13). In the population investigated, the addition of a centralised database to clinical monitoring resulted in very rapid detection of severe neutropenia and an equally rapid cessation of therapy. In the sample investigated, this led to very low morbidity and zero mortality.